Advertisement
Advertisement
NEPH
Nephros Inc.
3.52
USDSponsored
+0.29
+8.98%
May 08, 15:59 UTC -4
Closed
After-Market
3.56
+0.04
+1.16%
NEPH Earnings Reports
Positive Surprise Ratio
NEPH beat 16 of 28 last estimates.
57%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$4.92M
/$0.00
Implied change from Q1 26 (Revenue/ EPS)
-5.51%
/-100.00%
Implied change from Q2 25 (Revenue/ EPS)
+11.41%
/-100.00%
Nephros Inc. earnings per share and revenue
On May 07, 2026, NEPH reported earnings of 0.01 USD per share (EPS) for Q1 26, missing the estimate of 0.01 USD, resulting in a -1.96% surprise. Revenue reached 5.21 million, compared to an expected 5.12 million, with a 1.79% difference. The market reacted with a +8.98% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of 0.00 USD, with revenue projected to reach 4.92 million USD, implying an decrease of -100.00% EPS, and decrease of -5.51% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
Haemonetics Corporation
Report Date
May 07, 2026 For Q4 26
Estimate
$1.28
Actual
$1.29
Surprise
+0.42%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
FAQ
What were Nephros Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Nephros Inc. reported EPS of $0.01, missing estimates by -1.96%, and revenue of $5.21M, 1.79% above expectations.
How did the market react to Nephros Inc.'s Q1 2026 earnings?
The stock price moved up 8.98%, changed from $3.23 before the earnings release to $3.52 the day after.
When is Nephros Inc. expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Nephros Inc.'s next earnings report?
Based on 3
analysts, Nephros Inc. is expected to report EPS of -- and revenue of $4.92M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement